Akademisyen
TALHA MÜEZZİNOĞLU
PROFESÖR
MANİSA CELÂL BAYAR ÜNİVERSİTESİ TIP FAKÜLTESİ CERRAHİ TIP BİLİMLERİ BÖLÜMÜ
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 149
- Proje 0
- Kitap 7
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
15
Q2
30
Q3
42
Q4
3
WoS (JCR)
Q1
10
Q2
19
Q3
17
Q4
56
TR Index
62
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
4
Ort. yüzdelik
40.0%
Üst %1 payı
0.0%
Üst %10 payı
4.2%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Health-related quality of life after thulium fiber laser lithotripsy: a prospective study according to stone localization YÖKSİS SJR Q1 JCR Q1 OpenAlex 59.7%
- 2026 Advancing Prostate Cancer Diagnostics: Retrospective Insights Into Transperineal Biopsy as a Primary Approach YÖKSİS SJR Q2 JCR Q2 OpenAlex 7.4%
- 2026 Predictive Value of Vein Diameter Threshold and Clinical Factors in Semen Quality Improvement after Varicocelectomy YÖKSİS SJR Q3 JCR Q3 OpenAlex 19.6%
- 2026 Can ChatGPT-5 educate the public about vasectomy?: a Google Trends–based expert panel assessment YÖKSİS SJR Q1 JCR Q1 OpenAlex 23.0%
- 2026 Generative AI–Assisted Microlearning for Erectile Dysfunction Myth Reduction: Single-Center Pre–Post Quasi-Experimental Study YÖKSİS SJR Q2 JCR Q2 OpenAlex 19.9%
- 2026 What Changed in Partial Nephrectomy in the Last Decade? A Comparison of Surgical Management and Outcomes YÖKSİS TR Index JCR Q4 OpenAlex 22.4%
- 2025 Inflammatory and neuroimmune imbalance in diabetic incontinence: insights from serum biomarker profiling YÖKSİS SJR Q2 JCR Q2 OpenAlex 42.1%
- 2025 Effect of Bacillus Calmette-Guérin Instillation Timing on Oncological Survivals After Transurethral Resection of Bladder Tumor YÖKSİS SJR Q2 JCR Q2 OpenAlex 36.9%
- 2025 Predictive Value of Serum Biomarkers in Prostate Cancer Progression YÖKSİS SJR Q3 JCR Q4 OpenAlex 50.0%
- 2024 Oncological Outcomes of Chromophobe Versus Clear Cell Renal Cell Carcinoma: Results from A Contemporary Turkish Patient Cohort YÖKSİS SJR Q3 JCR Q4 OpenAlex 13.3%
- 2024 Can We Predict Recurrence of pT1-2 Renal Cell Carcinoma? YÖKSİS TR Index OpenAlex 5.4%
- 2024 Simultaneous Partial Nephrectomy and Radiofrequency Ablation in a Solitary Kidney Patient. YÖKSİS TR Index OpenAlex 33.7%
- 2024 Significance of Suspicious Urine Cytology (Class III) in Diagnostic Cystoscopy Follow-up of Bladder Cancer YÖKSİS TR Index OpenAlex 9.0%
- 2023 Treatment Options in Low-risk Prostate Cancer Patients: A Retrospective Database Report YÖKSİS OpenAlex 11.9%
- 2023 Asymptomatic Giant Renal Calculi: Single-Session Percutaneous Nephrolithotomy-Images YÖKSİS SJR Q4 JCR Q4 OpenAlex 45.7%
- 2023 Obstructive Uropathy in Advanced Prostate Cancer YÖKSİS TR Index OpenAlex 72.4%
- 2023 Oncological Outcomes of Patients with Non-Clear Cell Renal Cell Cancers: Subtypes of Unclassified and Translocation Renal Cell Cancers YÖKSİS SJR Q3 JCR Q3 OpenAlex 54.2%
- 2022 What Is Your Choice for Androgen Deprivation Therapy in Metastatic Prostate Carcinoma: Surgical or Medical? YÖKSİS TR Index SJR Q3 OpenAlex 45.4%
- 2022 The Effect of Postoperative Early Mobilization on the Healing Process and Quality of Life Following Radical Cystectomy and Ileal Conduit: A Randomized Prospective Controlled Trial YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 65.6%
- 2022 The Effect of Transurethral Resection and BCG Therapy on Cytokine Levels in Non-Muscle Invasive Bladder Cancer YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 19.6%